Chemical entities SHINE in the top 10 fastest-growing drugs of 2016
Global
pharmaceutical companies are increasingly focusing on the development of new
biologics. In fa
Pfizer’s US facility receives a warning letter, as Baxter’s cGMP deficiencies result in multi-million dollar legal settlement
Within two
months of 2017, we have already seen several pharmaceutical companies come
under the regu